SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Repertoire Partners LP

(Last) (First) (Middle)
345 CALIFORNIA STREET, SUITE 600

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/02/2023
3. Issuer Name and Ticker or Trading Symbol
Portman Ridge Finance Corp [ PTMN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 1,083,825 I See Note(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Equity Swap (obligation to buy)(2) 08/27/2021 08/27/2024 Common Stock 15,426 23.7618(2) I See Note(1)
Equity Swap (obligation to buy)(2) 11/29/2021 11/29/2024 Common Stock 37,489 24.488(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/03/2021 12/03/2024 Common Stock 20,178 24.5297(2) I See Note(1)
Equity Swap (obligation to buy)(2) 11/24/2021 11/24/2024 Common Stock 1,435 24.53(2) I See Note(1)
Equity Swap (obligation to buy)(2) 07/19/2021 07/19/2024 Common Stock 25,000 23.19(2) I See Note(1)
Equity Swap (obligation to buy)(2) 05/28/2021 05/28/2024 Common Stock 10,319 23.7385(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/10/2021 12/10/2024 Common Stock 10,798 24.4225(2) I See Note(1)
Equity Swap (obligation to buy)(2) 03/24/2021 03/24/2024 Common Stock 7,632 21.2654(2) I See Note(1)
Equity Swap (obligation to buy)(2) 11/26/2021 11/26/2024 Common Stock 3,642 24.4481(2) I See Note(1)
Equity Swap (obligation to buy)(2) 11/30/2021 11/30/2024 Common Stock 64,651 24.6301(2) I See Note(1)
Equity Swap (obligation to buy)(2) 06/29/2021 06/29/2024 Common Stock 593 23.8879(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/06/2021 12/06/2024 Common Stock 25,000 24.5296(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/02/2021 12/02/2024 Common Stock 4,127 24.5293(2) I See Note(1)
Equity Swap (obligation to buy)(2) 11/30/2022 11/30/2025 Common Stock 106 22.52(2) I See Note(1)
Equity Swap (obligation to buy)(2) 03/25/2021 03/25/2024 Common Stock 14,643 21.7256(2) I See Note(1)
Equity Swap (obligation to buy)(2) 10/07/2021 10/07/2024 Common Stock 64,922 23.9973(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/09/2021 12/09/2024 Common Stock 7,513 24.4044(2) I See Note(1)
Equity Swap (obligation to buy)(2) 09/01/2021 09/01/2024 Common Stock 9,912 23.9751(2) I See Note(1)
Equity Swap (obligation to buy)(2) 03/31/2021 03/31/2024 Common Stock 17,394 21.8799(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/15/2021 12/15/2024 Common Stock 32,940 24.3787(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/13/2021 12/13/2024 Common Stock 8,715 24.4102(2) I See Note(1)
Equity Swap (obligation to buy)(2) 12/14/2021 12/14/2024 Common Stock 13,016 24.4104(2) I See Note(1)
Explanation of Responses:
1. Repertoire Partners LP ("Repertoire") is the investment adviser to Repertoire Master Fund LP (the "Master Fund"). Repertoire Holdings LLC ("Holdings") is the general partner of the Master Fund. Deepak Sarpangal is the control person of both Repertoire and Holdings. These securities are held directly by the Master Fund for the benefit of its investors. The securities may be deemed to be beneficially owned by Repertoire as the investment adviser to the Master Fund, by Holdings as the general partner of the Master Fund and by Mr. Sarpangal as the control person of Repertoire and Holdings. Each of Repertoire, Holdings and Mr. Sarpangal disclaims beneficial ownership of such securities except to the extent of that person's pecuniary interest therein.
2. Pursuant to an equity swap agreement entered into by the Master Fund with a counterparty, upon expiration of the 3-year term of the agreement, (1) the Master Fund will be obligated to pay to the counterparty the price per share set forth in Column 4 for the notional number of shares of PTMN common stock set forth in Column 3, and (2) the counterparty will be obligated to pay to the Master Fund the market value of the notional number of shares of PTMN common stock set forth in Column 3 as of the end of that period. The Master Fund will pay to the counterparty monthly interest on the purchase price of the notional shares, at a rate tied to a market index, and the counterparty will pay to the Master Fund all dividends and similar distributions paid on an equivalent number of shares of PTMN common stock during the term.
Remarks:
Before 10/2/2023, the Master Fund reported the securities subject to this report and transactions in those securities. Effective as of 10/2/2023, the Master Fund beneficially owns less than 10% of the outstanding shares of the issuer and is no longer subject to the reporting requirement of Section 16(a) of the Securities and Exchange Act. While Repertoire previously did not file a Form 3 in reliance on Rule16a-1(a)(1)(v) under the Act, Repertoire is filing this Form 3 because it may be deemed to indirectly beneficially own more than 10% of the outstanding shares of the issuer. Repertoire is filing this Form 4 on behalf of itself, Holdings and Mr. Sarpangal. The filers are filing this Form jointly, but not as a group, and each expressly disclaims membership in a group.
/s/ Deepak Sarpangal, Managing Member of the General Partner of Repertoire Partners LP 10/05/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.